Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
US9060978B2 · kind B2 · utility
3Cited by
43References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 24, 2011 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Oct 24, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5031
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Effective methods of treating a spinal disorder or osteoarthritis associated with a proinflammatory agent in a patient in need of such treatment, the method comprising administering an effective amount of DN-TNF (e.g., XPro®-1595) to a target tissue site at or near the spine or osteoarthritic joint to reduce pain and/or inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.